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Claudia Neumann1, Ehrhardt Proksch1 and Jochen Brasch1
Tinea corporis is a superficial mycotic infection resulting in substantial epidermal changes. We determined skin
barrier function, epidermal differentiation, and human-b-defensin 2 (hBD-2) protein expression in 10 patients
with tinea corporis caused by Trichophyton rubrum (T. rubrum). We found disturbed skin barrier function as
shown by a significant increase in transepidermal water loss (TEWL) and specific ultrastructural changes
including disturbed formation of extracellular lipid bilayers, lamellar body extrusion, and deposit of clotted
material at the stratum granulosum/stratum corneum interface. Epidermal proliferation in tinea increased
several fold and accordingly, proliferation and inflammation-associated keratins K6, K16, and K17 were
expressed. Expression of basal keratins K5 and K14 increased, whereas differentiation-associated K10 was
reduced. Reduction of the cornified envelope proteins involucrin, loricrin, and the S100 protein filaggrin was
also seen. Reduced filaggrin expression correlated with reduced skin hydration; protein breakdown products of
filaggrin have been shown to be important for water binding. Surprisingly, we found pronounced epidermal
protein expression of hBD-2, which may be related to disturbed epidermal differentiation and inflammation.
hBD-2 showed a weak, although significant, antifungal activity against T. rubrum in the turbidimetric assay and
the immunohistological staining was somewhat less pronounced in areas directly underneath fungal hyphae in
the stratum corneum. Together, we describe profound changes in skin barrier structure and function, epidermal
proliferation, and differentiation including pronounced protein expression of hBD-2 in tinea corporis.
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INTRODUCTION
Superficial fungal skin infections cause a wide spectrum of
diseases in humans. Dermatophytes are highly specialized
pathogenic fungi, which primarily affect the stratum cor-
neum. Clinically superficial dermatophytosis causes erythe-
ma and scaling of the skin. Histology and periodic acid-Schiff
(PAS) staining, in particular, reveal that hyphae in superficial
dermatophytosis are present in the stratum corneum but do
not reach the living epidermis. Nevertheless, skin reactions to
dermatophytes involve the entire epidermis, histologically
seen as thickened epidermis with hyper-/parakeratosis and
acanthosis. In addition, an inflammatory infiltrate, primarily T
cells, and sometimes neutrophils, is visible in the upper
dermis (Brasch, 1990; Brasch and Sterry, 1992; Brasch et al.,
1993).
Erythema and scaling are also signs of eczema and
psoriasis. In not yet fully developed lesions, it is often
clinically difficult to distinguish between tinea, eczema, or
even psoriasis. Diagnosis of tinea may be difficult even with
routine histology using hematoxylin-and eosin-stained slides
because the epidermal architecture is sometimes similar to
eczema or psoriasis, in particular if neutrophils are present.
PAS staining can be necessary to detect hyphae in the stratum
corneum.
The stratum corneum, the main permeability barrier, is
formed from extracellular lipids and corneocytes during
epidermal differentiation of the skin (Elias, 1983). The main
extracellular stratum corneum lipids are cholesterol, free fatty
acids, and ceramides (Lampe et al., 1983; Elias and Menon,
1991). Specific ceramides are covalently bound to cornified
envelope proteins, particularly to involucrin, forming the
backbone for the subsequent attachment of free ceramides,
fatty acids, and cholesterol (Fuchs and Green, 1980; Cline
and Rice, 1983; Watt, 1983; Wertz et al., 1989; Mehrel et al.,
1990; Hohl, 1993; Marekov and Steinert, 1998). The
cornified envelope proteins are formed during epidermal
differentiation. Specific basal (K5 and K14) and suprabasal
(K1 and K10) keratins are also synthesized during the
differentiation process (Moll et al., 1982; Smack et al.,
1994), demonstrating that epidermal differentiation is cru-
cially involved in skin barrier function (Ekanayake-Mudiyan-
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selage et al., 1998). The antimicrobial barrier that contains
antimicrobial peptides is the second line of defense beyond
the permeability barrier (Zasloff, 1987; Harder et al., 1997;
Liu et al., 2002; Braff et al., 2005).
RESULTS
Fungal spectrum of superficial mycoses
Cultured fungi from superficial dermatomycoses on glabrous
skin (excluding feet) were recorded in our hospital over a
period of 3 years (2001–2003). Dermatophytes were identi-
fied in approximately 65% of 232 positive cultures, mostly
T. rubrum (48%), followed by T. mentagrophytes in merely
6%. Microsporum canis (2%) was found only in samples from
young patients; other dermatophytes were only rarely seen.
Candida species were identified in more than one-quarter of
the samples (29%); additional yeasts and molds were also
identified (15%).
Changes in transepidermal water loss (TEWL) and stratum
corneum hydration
As T. rubrum is by far the most common cause of superficial
dermatophytosis in adults in Germany, only patients with
tinea corporis and positive cultures for T. rubrum were
chosen for further study. In lesional T. rubrum-infected skin,
we found a highly significant increase in TEWL compared
with intraindividual healthy control skin from the same
region (þ243.1%, Po0.0001, n¼25; Figure 1a). Hydration
was significantly reduced in lesional epidermis compared to
control (24.3%, Po0.0001, n¼ 22; Figure 1b). These
results show that fungal infection significantly influences
TEWL and stratum corneum hydration.
Increased proliferation in the epidermis
It is well known that fungal infection results in scaling of the
skin. Scaling is very often the result of epidermal hyperpro-
liferation. Therefore, we examined epidermal proliferation
using the Ki-67 marker. We found that lesional skin exhibited
a highly significant sevenfold increased amount of labeled
cell nuclei in the basal cells and, to a lesser degree in the
lower spinous layers (involved epidermis: 16.072.21 cells/
visible field; uninvolved epidermis: 2.370.8 cells/visible
field; þ695%, Po0.001, n¼ 10; Figure 2). This demon-
strates a highly significant increase in proliferation in tinea
corporis.
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Figure 1. TEWL and hydration in healthy and lesional skin. TEWL
significantly increased in superficial dermatophytosis, indicating skin
permeability barrier impairment (þ 243.1%, Po0.0001, n¼ 25). Stratum
corneum hydration was reduced (24.3%, Po0.0001, n¼ 22).
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Figure 2. Changes in epidermal proliferation rate and differentiation. Using
Ki-67 antibodies, an increase in proliferation was seen in infected epidermis
(þ695%, Po0.001, n¼ 10). Epidermal differentiation showed changes in
involucrin, loricrin, filaggrin, anti-microbial hBD-2, and keratins.
Bar¼100 mm.
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Altered distribution of involucrin, loricrin, filaggrin, b-defensin
2, and keratins in the epidermis
Changes in epidermal proliferation are usually accompanied
by changes in epidermal differentiation. Therefore, we
examined epidermal keratins, cornified envelope proteins,
and filaggrin as markers of epidermal differentiation. In
addition, human-b-defensin-2 (hBD-2) expression was ex-
amined as an important antimicrobial peptide and also as a
marker of differentiation. Patterns of immunohistochemical
staining were similar in all patients studied with only slight
variations. Immunohistochemistry of differentiation-asso-
ciated proteins in lesional compared with uninvolved skin
of the same patient is shown in Figure 2.
In healthy epidermis, involucrin expression was confined
to the upper spinous layers and the stratum granulosum. Faint
staining of the spinous layers was only occasionally observed.
The band of epidermal involucrin staining significantly
broadened in tinea corporis and was found in all suprabasal
layers. Spots of staining were recognized even in the basal
cell layer. This result showed a premature expression of
involucrin in tinea corporis.
The zone stained for loricrin broadened in infected skin
compared with normal skin. Loricrin staining in healthy skin
was seen as a sharp band confined to the stratum granulosum.
In tinea corporis, faint broadening of the stained zone
occurred most probably owing to disease-related thickening
of the granular cell layer (hypergranulosis) in mycotic skin.
However, loricrin staining extended to the upper spinous
layers in an irregular pattern, showing broad gaps of
expression in lesional skin.
In healthy skin, filaggrin staining was found in the upper
granular layer and transition zone to the lower horny layers of
the skin. In lesional skin, the thickness of the stained band
increased. This was again due to the increased thickness of
the granular layer alongside an overall increase in epidermal
thickness. Although the stained band broadened, this band
contained gaps that resulted in decreased total staining for
filaggrin.
Remarkably, we found very strong expression of hBD-2 in
suprabasal epidermal layers with increasing staining from the
lower to mid-spinous layers into the granular layer of lesional
skin. In contrast, there was no staining for hBD-2 in healthy
skin. In double-staining analysis using PAS in combination
with a hBD-2 antibody, simultaneous staining for fungal
hyphae in the stratum corneum and strong staining for the
defensins in spinous and granular layers were noted (Figure 3).
Interestingly, staining intensity was somewhat less in areas
with high fungal load than in areas with low fungal load.
Immunostaining for basal K5 was primarily restricted to
the basal epidermal layer in healthy skin. In lesional skin,
extension to suprabasal epidermal layers occurred in a
homogeneous distribution, but staining intensity was sig-
nificantly reduced. Proliferation-associated K6 was not
expressed in healthy control skin. In contrast, pronounced
staining in the suprabasal layers appeared in lesional
mycotic-infected skin. Suprabasal differentiation-related K10
expression was found in the entire suprabasal compartment
in healthy controls. Staining for K10 was concentrated in the
granular and upper spinous layers in lesional skin, but was
reduced or absent in the lower spinous layers of the
epidermis. Immunostaining for basal keratin K14 was
localized in the basal and the lower spinous layers in control
skin. Staining of the entire nucleated epidermis occurred with
the highest staining intensity in lesional skin still in the basal
layer. For proliferation-associated keratin K16, there was faint
staining in the basal layer in healthy skin. In tinea, intense
staining occurred in all suprabasal layers. Inflammation-
associated K17 was not expressed in healthy skin. In lesional
skin, staining was found in suprabasal layers with increasing
intensity toward the stratum granulosum.
Weak, although significant, activity of hBD-2 against T. rubrum
A turbidimetric assay showed that the recombinant and the
natural hBD-2 in two concentrations expressed a weak,
although significant, antifungal activity against T. rubrum
(Figure 4) (Po0.05, n¼4). In contrast, fluconazole used as
control was highly active.
Impaired lamellar body extrusion and disturbed formation of
lipid bilayers in tinea
Dermatophyte hyphae are identified within the corneocytes
but also in the extracellular spaces of the stratum corneum.
Ultrastructural analysis revealed disturbed lamellar body
extrusion at the stratum granulosum/stratum corneum inter-
face and disturbed formation of extracellular lipid bilayers.
a
b
Figure 3. Colocalization of hyphae and hBD-2 expression. (a) Double
staining of hBD-2 and PAS shows a strong expression of hBD-2 in tinea
however, (b) with a slight reduction in areas underneath a high fungal hyphae
load. Bar¼ 50 mm.
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Bulged extracellular areas with clots of uneven material were
found in the stratum corneum of lesional skin (Figure 5).
DISCUSSION
As T. rubrum is by far the most frequent and important cause
of tinea corporis in adults in Germany (Brasch, 1990), we
focused our investigations on that single fungal species. A
diversity of mechanisms is considered relevant for its
interaction with an infected host. Similar to other dermato-
phytes, T. rubrum can release a broad panel of enzymes
including keratinases, aminopeptidase, and lipases that may
damage corneocytes and lead to extracellular growth of
hyphae (Das and Banerjee, 1977; Brasch et al., 1991; Da
Silva et al., 2005). Neutrophils are attracted by activation of
complement (Dahl, 1986) and probably by lipid-like factors
as well (Kahlke et al., 1996; Schro¨der et al., 2002).
In this study, we found a significantly impaired perme-
ability barrier in tinea corporis. TEWL, as a marker of barrier
function, increased more than threefold in lesional compared
with nonlesional skin from the same patients and the same
body area. Electron microscopy revealed disturbed lamellar
body extrusion and disturbed stratum corneum lamellar
bilayer organization, indicating a disturbed skin barrier
structure. We also showed that the fungal hyphae disrupted
the normal stratum corneum structure (Figure 5a). The
extracellular space in the stratum corneum shows clotted
material (Figure 5c), most likely the result of impaired
lamellar body content and extrusion (Figure 5b). This finding
is specific for tinea and has not been described before in
other diseases including atopic dermatitis, which also shows
disturbed barrier function and disturbed epidermal differ-
entiation (Fartasch et al., 1992). Our electron microscopy
studies point to the direct effects of fungal lipase on the
disturbance of lipid extrusion and deposit of clotted material.
However, we cannot rule out that the release of fungal
keratinases, which leads to injury to the keratinocyte
membrane, may cause inflammation followed by increased
proliferation and disturbed epidermal differentiation. Possi-
bly, both mechanisms may be active, although tinea corporis
induced by T. rubrum usually exhibits only moderate
inflammation. TEWL values in tinea were similar to the
values in lesional skin of atopic dermatitis (Jensen et al.,
Tubidimetric measurement of T.rubrum growth at days 2 and 3
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Figure 4. Turbidimetric analysis. Turbidimetric assay revealed that natural
(n-hBD-2) or recombinant (r-hBD-2) hBD-2 shows weak but statistically
significant (*Po 0.05, n¼ 4) antimicrobial activity against T. rubrum after 2
days (gray) or 3 days (black) of incubation. In contrast, fluconazole that served
as control was highly active (*Po 0.05, n¼ 4) compared with phosphate
buffer.
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Figure 5. Electron microscopy study of the transition zone between stratum
granulosum and stratum corneum. Ultrastructural analysis in tinea caused by
T. rubrum identified hyphae in the corneocytes (a, long arrow) and in the
extracellular space (a, short arrow). (b) Disturbed lamellar body extrusion at
the transition from the stratum granulosum (SG) to the stratum corneum (SC)
and lack of lipid bilayer formation are signs of the skin barrier disturbance.
(c) The extracellular space in the stratum corneum shows clotted material.
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2004) showing similar degrees of barrier disruption despite
different causes.
A disturbance in barrier function is accompanied or
caused by changes in epidermal proliferation and differentia-
tion. We have previously shown that epidermal DNA
synthesis increases during permeability barrier repair
(Proksch et al., 1991) and described a fivefold increase in
epidermal proliferation in atopic dermatitis (Jensen et al.,
2004). Here, we found a sevenfold increase in epidermal
proliferation in tinea corporis. Similar results have been
previously described in animal experiments (Tagami, 1985;
Tagami et al., 1985) and in annular tinea (Berk et al., 1976).
Proliferation removes dermatophytes that cannot be removed
by phagocytosis or immunoresponse because the hyphae
reside exclusively in the ‘‘dead’’ stratum corneum (Tagami
et al., 1989; Dahl, 1994).
Increased epidermal proliferation is often linked to
disturbed differentiation, as there may not be sufficient time
for proper differentiation during exaggerated cell renewal.
Epidermal differentiation is of crucial importance for the
integrity of the permeability barrier (Ekanayake-Mudiyanse-
lage et al., 1998). It is not surprising that proliferation-
associated cytokeratins were expressed in lesional tinea
corporis: intense staining for K6 and K16 in tinea in the
suprabasal layers similar to atopic dermatitis lesional skin
occurred (Jensen et al., 2004). The inflammation-associated
K17 was not expressed in healthy skin. In lesional skin,
staining was found in the upper spinous and the granular
layers. The staining was less pronounced in tinea compared
with atopic dermatitis (Jensen et al., 2004). This correlates
with the clinical and histological findings, as inflammation in
tinea corporis caused by T. rubrum is usually not severe.
Keratinocytes synthesize specific cytoskeleton basal (K5
and K14) and suprabasal (K1 and K10) keratins, as well as
cornified-envelope associated proteins, in particular involu-
crin, filaggrin, and loricrin (Fuchs and Green, 1980; Moll
et al., 1982; Cline and Rice, 1983; Watt, 1983; Hohl, 1993;
Ekanayake-Mudiyanselage et al., 1998). Basal keratin K5,
known to be extended into the suprabasal layers in atopic
dermatitis and dry skin (Engelke et al., 1997; Jensen et al.,
2004), almost entirely disappeared in the basal, lower, and
mid-spinous layers in tinea corporis. Moderate staining
appeared only in the upper spinous and the granular layers.
Staining for the second basal keratin K14 was no longer
restricted to the basal and lower spinous layers as in normal
skin, but was equally distributed with moderate staining
intensity in the entire nucleated epidermis. The expression of
suprabasal/differentiation-related K10 was significantly re-
duced. Staining for K10 in tinea was only found in the
granular and upper spinous layers and was focally disrupted.
The reduction in K10 staining was more pronounced in tinea
than atopic dermatitis, showing severely impaired differentia-
tion. Interestingly, filaggrin and involucrin were not signifi-
cantly changed in pityriasis versicolor, another mycotic
infection (Fang, 1994), where epidermal changes and scaling
are much less clinically apparent than in tinea corporis.
Involucrin staining was reduced in tinea corporis com-
pared with normal skin. Although the stained area broadened
in diseased skin, the intensity of the staining was significantly
reduced. Similar findings have been described in atopic
lesional skin (Jensen et al., 2004). Involucrin serves as a
substrate for the covalent attachment of ceramides to the
cornified envelope (Wertz et al., 1989; Marekov and Steinert,
1998). Very long chain length ceramides are covalently
bound to cornified envelopes of the corneocytes to form the
backbone for the attachment of free ceramides, cholesterol,
and fatty acids. A reduction in involucrin may result in
reduced ceramide binding, which consequently reduces
barrier function. In lesional skin of atopic dermatitis, together
with a reduction of involucrin, the amount of protein-bound
o-hydroxyceramides was significantly reduced (Macheleidt
et al., 2002; Jensen et al., 2004). Loricrin staining was
confined to the granular layers in tinea corporis and in
normal skin. The stained band also broadened in tinea
because of broadening of the granular layer; however,
staining intensity was reduced and even focally absent. In
contrast, we found increased loricrin expression in atopic
lesional skin, showing that there are differences in the
differentiation process between eczema and tinea. The genes
for filaggrin, involucrin, and loricrin are localized on the
same gene 1q21, also known as the epidermal differentiation
complex (Yoneda et al., 1992). Therefore, coordinated
regulation of the three cornified envelope proteins is most
likely. Hohl (1993) described overexpression of loricrin and
involucrin in orthokeratotic acanthosis, such as lichen
planus. In unspecified dermatitis, however, he found reduced
loricrin expression (Hohl, 1993). The reason for the
differences in loricrin content between tinea, atopic derma-
titis, and other skin diseases remains unknown.
Filaggrin is an S100 protein and a marker of epidermal
differentiation. It has been suggested that filaggrin degrada-
tion products are most important for water binding (Scott and
Harding, 1986). We recently described reduced filaggrin
content in atopic dermatitis and related these changes to the
well-known dry skin associated with that disease (Jensen
et al., 2004). Very recently, mutations in the filaggrin gene
were found in up to 50% of atopic dermatitis patients of
European heritage (Palmer et al., 2006; Ruether et al., 2006).
In tinea corporis, we also found focally broadened staining
for filaggrin but reduced staining intensity and broad gaps
showing reduced content. This correlates with a significant
reduction of skin hydration values as we found here. Skin
hydration was reduced to about the same values as in lesional
atopic dermatitis (Jensen et al., 2004).
In this study, we found strong staining intensity of the
antimicrobial protein hBD-2 in the spinous and granular
layers of tinea corporis. Similarly, the expression of hBD-2 in
candidal leukoplakia (Abiko et al., 2002; Meyer et al., 2004;
Schneider et al., 2005) and in Malassezia furfur infection has
been described (Donnarumma et al., 2004). However, using
double-staining technique, we showed that expression
appeared to be most pronounced in areas with only scattered
fungal elements. hBD-2 expression was somewhat less
pronounced in areas beneath a high fungal hyphae load,
meaning that fungal hyphae most probably do not directly
cause increased hBD-2 protein expression, but instead
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suppress defensin expression. It was recently found that
hyphae invasion of Candida albicans inhibits the expression
of human b-defensins in experimental oral candidiasis (Lu
et al., 2006). We showed here that natural and the
recombinant hBD-2 have a weak antifungal activity against
T. rubrum, compared with fluconazole. Therefore, it is most
likely that hBD-2 expression is a secondary event in fungal
infection and may be related to disturbed differentiation and
induction of cytokines. T. mentagrophytis has been shown to
induce tumor necrosis factor and IL-8 production in
keratinocytes (Nakamura et al., 2002). Tumor necrosis factor
and IL-1, in particular, are potent inducers of hBD-2
expression (Harder et al., 2000), showing that inflammation
induced by the pathogen causes the increase in hBD-2
expression in tinea corporis (Miyata et al., 1996; Ohta et al.,
1998). However, keratinocytes may express hBD-2 as a
protective response against bacterial superinfection, because
tinea can be colonized by bacteria (Pomeranz and Fairley,
1994; Masri-Fridling, 1996). hBD-2’s antibacterial activity is
already well known (Schro¨der and Harder, 2006). Thus,
increased hBD-2 expression may be an attempt to strengthen
antibacterial activity and substitute for the impaired physical
barrier in tinea. In conclusion, we propose that superficial
dermatophytosis attributable to infection with T. rubrum
results in disturbed skin barrier function, reduced stratum
corneum hydration, enhanced proliferation, and changes in
epidermal differentiation including induction of hBD-2
expression.
MATERIALS AND METHODS
Patients
Skin scrapings from 232 patients with tinea corporis were examined
by KOH preparation and the fungal pathogens were cultured and
identified by standard methods (Meinhof, 1990; Campbell
et al.,1996; Kane et al., 1997). Skin biopsies for immunohistochem-
istry and proliferation assays were obtained from tinea corporis-
infected and nonlesional skin from the backs or thighs of a
representative group of adult patients. Individuals showing an
untreated, superficial dermatophytosis proven by fungal culture
techniques were included in the study. The local ethical commission
approved the study protocol, prepared in accordance with the
Declaration of Helsinki Principles, and all patients fully consented to
participate in the study.
TEWL and stratum corneum hydration
We determined TEWL and stratum corneum conductance by
biophysical methods to examine whether our patients exhibited
changes in barrier function and stratum corneum hydration
(Pinnagoda et al., 1990; Hashimoto-Kumasaka et al., 1993). Skin
hydration and TEWL were measured noninvasively with a Tewa-
meter TM210 and a Corneometer (both Courage & Khazaka,
Cologne, Germany) in lesional and healthy skin as intraindividual
control (Jensen et al., 2004).
Immunohistochemistry staining
Punch biopsies were fixed in formalin and embedded in paraffin.
Hematoxylin and eosin and PAS stains were performed to confirm
tinea infection. After deparaffination and rehydration, 5-mm-thick
sections were incubated with 3% H2O2 for 5 minutes to block
endogenous peroxidase activity and the rinsed sections were
exposed to 5 5 minutes microwave irradiation (650 W) for antigen
detection (Hazelbag et al., 1995). After blocking non-specific
antibody binding by incubation with 20% normal pig serum (DAKO,
Hamburg, Germany), the primary antibodies (anti-involucrin, anti-
loricrin, anti-filaggrin, anti-hBD-2, or anti-keratin 5, 6, 10, 16, and
17) were applied (Rosenthal et al., 1992; Hohl, 1993). A goat anti-
hBD-2 antibody was purchased from PeproTech (Rocky Hill, NJ). A
strep–AB complex/HRP (DAKO, Hamburg, Germany) was used as a
third antibody, followed by incubation with diaminobenzidine as
peroxidase substrate. Some representative slides were subjected to
double staining for fungi PAS and hBD-2 (immunostaining) to
investigate colocalization.
Epidermal proliferation assay
As described for the previously mentioned histological slides, slides
were generated and incubated with Ki-67 antibodies. The stained
sections (one per slide) were examined microscopically (160 ) by
counting the labeled nuclei of interfollicular keratinocytes in seven
microscopic fields per section. Labeling index in samples of patients
with superficial dermatophytosis was defined by numbers of stained
cells per millimeter epidermal basal membrane.
Turbidimetric assay
Turbidimetric antifungal susceptibility assay was performed analo-
gously to Meletiadis et al. (2003). T. rubrum microconidia
suspension was adjusted to two times 105 conidia/ml in 10 mM
phosphate buffer (pH 7.3). Natural hBD-2 (n-hBD-2) extracted from
psoriasis scales (Harder et al., 1997) and recombinant hBD-2 (r-
hBD-2) (Sahly et al., 2006) were used in two dilutions, 25 and
100mg/ml in 0.01% acetic acid. Phosphate buffer, 0.01% acetic
acid, and 200mg/ml fluconazole in phosphate buffer served as
negative and positive control. Fifty microliters of conidia suspension
were incubated with 50ml dissolved agent (resulting in a concentra-
tion of hBD-2 of 12.5 and 50 mg/ml) or control for 2 hours at room
temperature with continuous shaking in the wells of microtiter
plates. Then, 100ml Sabouraud broth was added to each well. In
addition, to one well with conidia suspension, only 100 ml phosphate
buffer was added. Photometric measurements (wavelength 620 nm)
to determine turbidimetric growth curves were made at the start point
(day 0) and at days 1, 2, and 3. Each test was carried out in duplicate.
Chemical fixation and ultramicrotomy for transmission
electron microscopy
Skin samples were prefixed overnight in modified Karnovsky’s
medium at 41C, washed twice with 0.2 M sodium cacodylate buffer
for 10 minutes, and postfixed with 1% (wt/vol) OsO4 or RuO4 in
0.133 M sodium cacodylate buffer containing 0.5% (wt/vol)
K4Fe(CN)6 at 41C for 45 minutes (Elias and Friend, 1975). Specimens
were dehydrated in ethanol and embedded in Epon 812 (Luft, 1961).
Polymerization was carried out overnight at 601C. Thin sections
were cut with a Reichert Jung Ultracut E microtome with a diamond
knife (Diatome, Biel, Switzerland), counterstained with uranyl
acetate and lead citrate and examined in a CM 10 (Fei, Eindhoven,
The Netherlands) (Reynolds, 1963). OsO4 fixation was used to show
lamellar body extrusion and RuO4 was used to show stratum
corneum lipid bilayers.
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Statistical analysis
Statistical significance was determined using two-tailed Student’s
t-test. Each sample was measured in duplicate and the results are
presented as the mean7SEM.
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